Kwality Pharmaceuticals Ltd — Board Meeting, 19-05-2026: Board Meeting

KWALITY PHARMA's board approved FY26 audited results. Annual revenue hit a record ₹503 Cr, up 36% YoY. PAT jumped 69% to ₹67.3 Cr, with margin expansion. Company projects ₹650 Cr revenue and ₹100 Cr PAT for FY27, backed by strong pipeline & global expansion.